TOP BI-0115 SECRETS

j Experimental timeline for YGS pretreatment ahead of transduction with pSARS-CoV-2. k, l ACE2+ (k) and ACE2/TMPRSS2+ (l) cells were being pretreated with serial threefold dilutions of YGS in a beginning focus of 100 mg/ml for twenty min four occasions at 4 h intervals then transduced with pSARS-CoV-2 without the need of YGS. m PG syrup, main